rs71561434

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015571.4(SENP6):​c.-523C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0953 in 153,900 control chromosomes in the GnomAD database, including 739 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.095 ( 728 hom., cov: 33)
Exomes 𝑓: 0.087 ( 11 hom. )

Consequence

SENP6
NM_015571.4 5_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.804

Publications

7 publications found
Variant links:
Genes affected
SENP6 (HGNC:20944): (SUMO specific peptidase 6) Ubiquitin-like molecules (UBLs), such as SUMO1 (UBL1; MIM 601912), are structurally related to ubiquitin (MIM 191339) and can be ligated to target proteins in a similar manner as ubiquitin. However, covalent attachment of UBLs does not result in degradation of the modified proteins. SUMO1 modification is implicated in the targeting of RANGAP1 (MIM 602362) to the nuclear pore complex, as well as in stabilization of I-kappa-B-alpha (NFKBIA; MIM 164008) from degradation by the 26S proteasome. Like ubiquitin, UBLs are synthesized as precursor proteins, with 1 or more amino acids following the C-terminal glycine-glycine residues of the mature UBL protein. Thus, the tail sequences of the UBL precursors need to be removed by UBL-specific proteases, such as SENP6, prior to their conjugation to target proteins (Kim et al., 2000 [PubMed 10799485]). SENPs also display isopeptidase activity for deconjugation of SUMO-conjugated substrates (Lima and Reverter, 2008 [PubMed 18799455]).[supplied by OMIM, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SENP6NM_015571.4 linkc.-523C>T 5_prime_UTR_variant Exon 1 of 24 ENST00000447266.7 NP_056386.2 Q9GZR1-1B3KMM0
SENP6NM_001100409.3 linkc.-523C>T 5_prime_UTR_variant Exon 1 of 23 NP_001093879.1 Q9GZR1-2B3KMM0
SENP6NM_001304792.2 linkc.-523C>T 5_prime_UTR_variant Exon 1 of 15 NP_001291721.1 Q9GZR1F8W6D9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SENP6ENST00000447266.7 linkc.-523C>T 5_prime_UTR_variant Exon 1 of 24 1 NM_015571.4 ENSP00000402527.2 Q9GZR1-1

Frequencies

GnomAD3 genomes
AF:
0.0955
AC:
14508
AN:
151980
Hom.:
727
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0787
Gnomad AMI
AF:
0.0976
Gnomad AMR
AF:
0.0895
Gnomad ASJ
AF:
0.0939
Gnomad EAS
AF:
0.0387
Gnomad SAS
AF:
0.102
Gnomad FIN
AF:
0.127
Gnomad MID
AF:
0.102
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.101
GnomAD4 exome
AF:
0.0875
AC:
158
AN:
1806
Hom.:
11
Cov.:
0
AF XY:
0.0968
AC XY:
110
AN XY:
1136
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30
American (AMR)
AF:
0.0833
AC:
2
AN:
24
Ashkenazi Jewish (ASJ)
AF:
0.0357
AC:
1
AN:
28
East Asian (EAS)
AF:
0.0870
AC:
4
AN:
46
South Asian (SAS)
AF:
0.104
AC:
22
AN:
212
European-Finnish (FIN)
AF:
0.0161
AC:
1
AN:
62
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.0930
AC:
122
AN:
1312
Other (OTH)
AF:
0.0652
AC:
6
AN:
92
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0954
AC:
14516
AN:
152094
Hom.:
728
Cov.:
33
AF XY:
0.0958
AC XY:
7121
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.0788
AC:
3272
AN:
41532
American (AMR)
AF:
0.0894
AC:
1368
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0939
AC:
326
AN:
3470
East Asian (EAS)
AF:
0.0390
AC:
201
AN:
5156
South Asian (SAS)
AF:
0.102
AC:
494
AN:
4822
European-Finnish (FIN)
AF:
0.127
AC:
1344
AN:
10554
Middle Eastern (MID)
AF:
0.0959
AC:
28
AN:
292
European-Non Finnish (NFE)
AF:
0.106
AC:
7183
AN:
67944
Other (OTH)
AF:
0.0997
AC:
211
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
668
1337
2005
2674
3342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.103
Hom.:
106
Bravo
AF:
0.0891
Asia WGS
AF:
0.0700
AC:
243
AN:
3472

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
16
DANN
Benign
0.97
PhyloP100
0.80
PromoterAI
-0.017
Neutral
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.1
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71561434; hg19: chr6-76311718; API